Global Public Relations Executive Joins Lymphoma Research Foundation Board of Directors

Lymphoma Research Foundation Elects Allison+Partners Co-Founder Scott Pansky to Esteemed Board

Photo of Scott Pansky wearing a plaid button down shirt and glasses
Scott Pansky

The Lymphoma Research Foundation (LRF) is proud to announce the election of Scott Pansky of Los Angeles, CA to its Board of Directors.

The Lymphoma Research Foundation’s Board of Directors is comprised of business leaders, medical professionals, and Foundation supporters from across the United States who utilize their skills and expertise to further the LRF mission. Foundation Directors are responsible for supporting the mission, policies, and activities of the Lymphoma Research Foundation, establishing policies and programmatic goals; and monitoring the organization’s finances.

“I am pleased to welcome Scott Pansky to the esteemed Board of the Lymphoma Research Foundation,” said Steven Eichberg, Chair of the LRF Board of Directors. “Members of the Board of the Directors are critical to our success, and we are fortunate to have Scott join this dedicated group of individuals and share his expert thought leadership to support the LRF mission.”

Pansky is co-founder of Allison+Partners, one of the fastest-growing global communications firms in the industry and leads the agency’s Social Impact practice. He developed the agency’s proprietary Corporate Socialanthropy™ process, which helps corporations identify social impact partners and builds the foundation for long-term campaigns that incorporate employee recruitment and retention programs, internal and external communications, and cause-related marketing strategies. He worked has with numerous nonprofit organizations over the past 30 years, helping develop fundraising, marketing, and communication strategies. Prior to Allison+Partners, Pansky opened the Los Angeles office of Connors Communications and spent eight years with The Gable Group.

“Over the past seven years, I have had the wonderful opportunity of helping develop LRF’s Ambassador Program, and am so invigorated by the Foundation’s mission and its positive impact on the lymphoma community,” said Pansky. “I’ve seen first-hand the incredible leadership presented by the LRF Board of Directors and Scientific Advisory Board, and the Foundation’s role in advancing lymphoma research and supporting patients, survivors, and their loved ones. I am dedicated to echo that commitment in my new role as an LRF Director.”

For more information on the Lymphoma Research Foundation’s Board of Directors, visit lymphoma.org/bod.